Researchers found that receiving the Shingrix shingles vaccine may significantly lower the risk of developing dementia in older adults. A recent study involving over 500,000 people aged 66 and older showed that those who received at least one dose of the vaccine had a 24% reduced risk of dementia over four years compared to those who did not get vaccinated. This suggests that for every 17 individuals vaccinated, one case of dementia could potentially be prevented.

This finding is particularly relevant for older adults and their families who are concerned about cognitive decline. Given that dementia affects memory and daily functioning, reducing the risk through vaccination could improve quality of life and independence for many individuals. The study analyzed data from Medicare and health records of older adults admitted to skilled nursing facilities, emphasizing the importance of vaccination in this vulnerable population.

However, it’s essential to note that while the study presents promising findings, it does not prove a direct cause-and-effect relationship between the vaccine and reduced dementia risk. The participants who received the vaccine were generally younger and healthier, which could also influence the outcomes. Further research, including clinical trials, is needed to confirm these results and understand the underlying mechanisms. Nonetheless, the study highlights the potential cognitive benefits of an already accessible vaccine, suggesting that protecting physical health may also have positive effects on brain health.